From: Immunomodulatory and antitumour effects of abnormal Savda Munziq on S180 tumour-bearing mice
Group | Dosage (g/kg) | Thymus weight / Mouse weight (mg/g) | Spleen weight / Mouse weight (mg/g) | Liver weight / Mouse weight (mg/g) | Tumour Inhibition (%) |
---|---|---|---|---|---|
Control group | 0 | 3.3 ± 0.5 | 3.1 ± 0.4 | 39.9 ± 2.8 | 0 |
Model group | 0 | 2.8 ± 0.9 | 3.6 ± 0.4 | 40.1 ± 2.9 | 0 |
CY | 0.02 | 2.6 ± 0.3 | 2.9 ± 0.4 | 44.3 ± 3.0 | 50.88 |
ASMq low | 2 | 3.6 ± 0.4# | 4.0 ± 0.5*# | 49.4 ± 6.0*# | 43.43 |
ASMq medium | 4 | 3.0 ± 0.7 | 4.2 ± 1.0*# | 46.8 ± 13.2 | 64.26 |
ASMq high | 8 | 3.5 ± 0/7# | 3.5 ± 0.3*# | 40.8 ± 4.4 | 49.05 |